Enhanced activation of the repressed Epstein-Barr viral genome by inhibitors of DNA synthesis.
D002051:Burkitt Lymphoma; D002460:Cell Line; D002471:Cell Transformation, Neoplastic / Q000187:drug effects; D003561:Cytarabine / Q000494:pharmacology*; D004247:DNA / Q000096:biosynthesis*; D005838:Genotype; D004854:Herpesvirus 4, Human / Q000187:drug effects*; D006918:Hydroxyurea / Q000494:pharmacology*; D008938:Mitosis; D013936:Thymidine / Q000494:pharmacology; D013997:Time Factors; D014779:Virus Replication
D003561:Cytarabine; D004247:DNA; D013936:Thymidine; D006918:Hydroxyurea